7-Jan-2026
Magnera (MAGN) Gets a Buy from Wells Fargo
TipRanks (Tue, 6-Jan 6:37 AM ET)
Globe Newswire (Wed, 3-Dec 10:45 AM ET)
Market Chameleon (Mon, 24-Nov 6:53 AM ET)
Magnera Announces Participation in the 2025 Bank of America Leveraged Finance Conference
Globe Newswire (Mon, 24-Nov 11:32 AM ET)
Magnera Posts Robust Q4 and Fiscal Year Results: Cash Flow and Debt Reduction Take Center Stage
Market Chameleon (Thu, 20-Nov 4:53 AM ET)
Magnera Delivers Record Cash Flow and Sets Sights on Earnings Growth for 2026
Market Chameleon (Thu, 20-Nov 2:59 AM ET)
Magnera Reports Fourth Quarter and Fiscal Year Results
Globe Newswire (Wed, 19-Nov 6:34 PM ET)
Globe Newswire (Tue, 18-Nov 8:00 AM ET)
Magnera to Report Fourth Quarter and Fiscal Year 2025 Results on November 20th
Globe Newswire (Mon, 27-Oct 5:39 PM ET)
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
Magnera trades on the NYSE stock market under the symbol MAGN.
As of January 7, 2026, MAGN stock price declined to $14.34 with 657,390 million shares trading.
MAGN has a beta of 1.28, meaning it tends to be more sensitive to market movements. MAGN has a correlation of 0.16 to the broad based SPY ETF.
MAGN has a market cap of $510.50 million. This is considered a Small Cap stock.
Last quarter Magnera reported $839 million in Revenue and -$1.12 earnings per share. This beat revenue expectation by $943,920 and missed earnings estimates by -$1.25.
The top ETF exchange traded funds that MAGN belongs to (by Net Assets): VTI, IWM, VXF, IWN, FNDA.
MAGN has underperformed the market in the last year with a price return of -23.0% while the SPY ETF gained +18.4%. However, in the short term, MAGN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +22.7% vs +3.4% return in SPY. But in the last 2 weeks, MAGN shares have been beat by the market, returning -4.6% compared to an SPY return of -0.1%.
MAGN support price is $14.74 and resistance is $15.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MAGN shares will trade within this expected range on the day.